Pharmax India Private Limited

Pharmax India Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH1959PTC011403 Incorporated 20 July 1959 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹66.65 Cr
▲ 2% YoY
Net profit · FY 2024
₹8.19 Cr
Net margin 12.3%
EBITDA · FY 2024
₹13.45 Cr
EBITDA margin 20.2%
Authorised capital
₹3.8 Cr
Registered with MCA
Paid-up capital
₹1.26 Cr
Issued & subscribed
Open charges
₹20.7 Cr
Satisfied ₹5.03 Cr
Company age
67 yrs
Est. 1959
Employees · EPFO
54
Provident fund records

About Pharmax India Private Limited

Data last updated:

Pharmax India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 1959 and has been in existence for over 67 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1959PTC011403. Its GSTIN is 27AAACP7205K1ZD (Maharashtra). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3.8 Cr and a paid-up capital of ₹1.26 Cr. It was formerly known as Pharmax Private Limited. It is led by directors including Sarvesh Bishan Bansal (Managing Director) and Bimlesh Bansal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹66.65 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹8.19 Cr (net margin 12.3%) and EBITDA of ₹13.45 Cr (EBITDA margin 20.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 17% over five years.

The company has about 54 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Pharmax India. As per MCA filings, the company has open charges of ₹20.7 Cr and satisfied charges of ₹5.03 Cr on record. Court records list 33 cases involving the company, including 10 filed by the company and 23 filed against it; 5 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹76.4 Lakh; the latest was in March 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is United Bioceuticals Private Limited with revenue of ₹67.35 Cr. The company has 2 MSME Form 1 returns on record between 2022 and 2023, listing 7 overdue payments to 6 micro and small suppliers.

Pharmax India Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0026969). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaxindia.com.

Company details

CIN U24100MH1959PTC011403
Registration Number 011403
Incorporation Date 20 July 1959
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0026969
Key People
Sarvesh Bishan Bansal Managing Director Bimlesh Bansal Director Suyash Bansal Director

Recognitions & Rankings of Pharmax India

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-18-0026969

Contact details

Pharmax India Private Limited's registered office is in Mumbai, Maharashtra. Its website is pharmaxindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    pharmaxindia.com
  • Registered Address
    405 Town Centre 2, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Pharmax India Private Limited, buy the company report.

Comprehensive company report
Pharmax India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Pharmax India operates one associated brand: Pharmax India. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmax India
R&D-based pharmaceutical company specializing in manufacturing, distribution, and export of formulations and APIs.pharmaxindia.com

Business activity

The main business activity of Pharmax India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pharmax India Private Limited, buy the company report.

Financials of Pharmax India Private Limited

FY 2024 filings available

Pharmax India Private Limited reported revenue of ₹66.65 Cr (up 2% YoY) for FY 2024.

Revenue · FY 2024
₹66.65 Cr ▲ 2%
Net profit · FY 2024
₹8.19 Cr margin 12.3%
EBITDA · FY 2024
₹13.45 Cr margin 20.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 3%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 1%
5 years · compounded
▲ 30%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 2% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹13.45 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.19 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin20.2%
Net Profit Margin12.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pharmax India Private Limited, buy the company report.

Board of directors of Pharmax India Private Limited

Pharmax India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bimlesh Bansal
Also directs: Pharmax Renewable Private Limited
Director14 Mar 199432 Years 7 MonthsCurrent
Sarvesh Bishan Bansal
Also directs: Pharmax Renewable Private Limited, Pharmax Global Private Limited
Managing Director31 Aug 199432 Years 2 MonthsCurrent
Suyash Bansal
Also directs: Pharmax Global Private Limited
Director28 Sep 20179 Years 1 MonthsCurrent
View all directors

Peer comparison

Pharmax India Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
United Bioceuticals Private Limited₹67.35 Cr (FY 2024)31.0%New Delhi, Delhi, India
Samson Laboratories Private Limited₹67.3 Cr (FY 2025)13.0%Delhi, India
Premium Serums and Vaccines Private Limited₹67.25 Cr (FY 2025)28.0%Mumbai, Maharashtra, India
Pharmax India Private Limitedthis company₹66.65 Cr (FY 2024)₹8.19 Cr12.3%2.0%54Mumbai, Maharashtra, India
Swefn Pharmaceuticals Private Limited₹66.63 Cr (FY 2025)9.0%Moraiya, Gujarat, India
Merril Pharma Private Limited₹66.57 Cr (FY 2025)25.0%Ahmedabad, Gujarat, India
Hiral Labs Limited₹66.46 Cr (FY 2025)6.0%Ahmedabad, Gujarat, India
Skyec Drugs and Pharmaceuticals Private Limited₹66.27 Cr (FY 2025)19.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Pharmax India Private Limited, buy the company report.

Auditor

Pharmax India Private Limited is audited by Manish D. Ladage for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Manish D. LadageFY 202339898

Shareholding

The shareholding of Pharmax India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pharmax India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹20.7 Cr
Satisfied charges
₹5.03 Cr
Breakdown by lending institutions
Others₹20.40 Cr
State Bank of India₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Jan 2024100877895Others₹35 LakhOpen
20 May 2022100578375Others₹1.3 CrOpen
27 Mar 2021100435052Others₹18.75 CrOpen
10 Jun 199490366035State Bank of India₹30 LakhOpen
12 May 198890363119State Bank of India₹45,000Open

To see the full charge records of Pharmax India Private Limited, buy the company report.

Total charge records: 12 View all charges

Deals & funding

Pharmax India Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹76.4 Lakh; the latest was in March 2024.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹76.4 Lakh

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2024Funding round₹12.6 LakhInvestors: Smick Laboratories Private Limited
Feb 2021Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2013Secondary share transferUndisclosedBuyer: 3 individuals
Seller: Kaalyogi Infra Developers
Mar 2012Funding round₹63.8 LakhInvestors: Kaalyogi Infra Developers, 2 individuals
Mar 2012Secondary share transferUndisclosedBuyer: Kaalyogi Infra Developers, 3 individuals
Seller: Umanath Investment Pvt Ltd , 3 individuals

To see the full deal history of Pharmax India Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Pharmax India Private Limited has 2 MSME Form 1 returns on record between 2022 and 2023, listing 7 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Europack Machines (India) Private Limited
Silvassa Flexible Printers Private Limited
an individual supplier
K B Impex
Jinarth Enterprises

To see the full MSME payment records of Pharmax India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Pharmax India Private Limited has a workforce of 54 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
54
Active EPFO establishments
1
Employee growth
5.88%

GST

Pharmax India has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAACP7205K1ZDMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Pharmax India Private Limited, buy the company report.

Recent activity

Pharmax India Private Limited has 5 board changes on record since 1994: 3 appointments and 2 cessations. The latest: Suyash Bansal ceased to be Additional Director on 30 Sep 2017.

Charges
A charge with Others of Rs. 18.75 Cr registered on 27 Mar 2021 with Charge ID 100435052 was modified on 23 Dec 2024.
AGM
Pharmax India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pharmax India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100877895 was registered on 17 Jan 2024.
Charges
A charge with Others amounted to Rs. 1.30 Cr with Charge ID 100578375 was registered on 20 May 2022.
Charges
A charge with Others amounted to Rs. 18.75 Cr with Charge ID 100435052 was registered on 27 Mar 2021.
Ceased
Suyash Bansal ceased to be Additional Director.
Ceased
Sarvesh Bishan Bansal ceased to be Director.
Appointed
Suyash Bansal was appointed as Director.
Charges
A charge registered on 07 Jun 2001 via Charge ID 90364963 with Rupee Co. Op. Bank Ltd. was fully satisfied on 31 Jan 2017.
Charges
A charge registered on 30 Mar 2001 via Charge ID 90364961 with Rupee Co. Op. Bank Ltd. was fully satisfied on 31 Jan 2017.
Charges
A charge registered on 30 Mar 2001 via Charge ID 90366092 with Rupee Co. Op. Bank Ltd. was fully satisfied on 31 Jan 2017.

18 earlier events are in the company report.

Frequently asked questions

Pharmax India is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 1959 (67+ years old) and is registered under CIN U24100MH1959PTC011403.

Pharmax India has 3 current directors:

The latest financial statements of Pharmax India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Pharmax India is 27AAACP7205K1ZD, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Pharmax India is U24100MH1959PTC011403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pharmax India has 33 court cases on record: 10 filed by the company and 23 filed against it. 5 are pending. Most are in the district courts.

Pharmax India was incorporated on 20 July 1959, making it 67+ years old. It is registered with the Registrar of Companies, Mumbai.

Pharmax India has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹76.4 Lakh; the latest was in March 2024.

The peers of Pharmax India by revenue are United Bioceuticals Private Limited, Samson Laboratories Private Limited, Premium Serums and Vaccines Private Limited, Swefn Pharmaceuticals Private Limited, Merril Pharma Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Suyash Bansal ceased to be Additional Director on 30 Sep 2017. Sarvesh Bishan Bansal ceased to be Director on 28 Sep 2017. Suyash Bansal was appointed as Director on 28 Sep 2017. Pharmax India has 5 board changes on record in total.

Yes, Pharmax India is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0026969).

Pharmax India has 2 MSME Form 1 returns on record between 2022 and 2023, listing 7 overdue payments to 6 micro and small suppliers. The latest return was filed on 29 Apr 2023.